Empiric antimicrobial therapy of febrile neutropenic patients undergoing haematopoietic stem cell transplantation

International Journal of Antimicrobial Agents

Volumn 13, Issue 2, 1999, Pages 127-130

  Antabli, Bassema A ^a   Bross, Peter ^a   Siegel, Robert S ^a   Small, Connie D ^a   Tabbara, Imad A ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Empiric antibiotic therapy; Febrile neutropenia; Haematopoietic stem cell transplantation

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EMPIRICISM; FEBRILE NEUTROPENIA; FEMALE; FEVER; HEMATOPOIETIC CELL; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; VOMITING;

ADOLESCENT; ADULT; AGED; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; BONE MARROW TRANSPLANTATION; CEFTAZIDIME; CEPHALOSPORINS; CIPROFLOXACIN; FEMALE; FEVER; FEVER OF UNKNOWN ORIGIN; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MYCOSES; NEOPLASMS; NEUTROPENIA;

EID: 0033213515     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(99)00107-7     Document Type: Article

References (20)

1. Bodey G.P., Buckley M., Sathe Y.S., Freireich E.J. Quantitative relationship between circulating leukocytes and infection in patients with acute leukemia. Ann. Intern. Med. 64:1966;3.
2. Hathorn J.W., Pizzo U.A. Infectious complications in the pediatric cancer patient. Pizzo P.A., Poplack D.G. Principles and Practice of Pediatric Oncology. 1989;837-867 Lippincott, Philadelphia, PA.
3. Bayston K.F., Want S., Cohen J. A prospective, randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with fever. Am. J. Med. 87(suppl 5A):1989;269-273.
4. Klatersky J. Empiric treatment of infections in neutropenic patients with cancer. Rev. Infect. Dis. 5:1983;21-31.
5. Lieschke G.H., Bell D., Rawlinson W. et al. Empiric single agent or combination antibiotic therapy for febrile episodes in neutropenic patients: An overview. Eur. J. Cancer Clin. Oncol. 25:1989;37-42.
6. Schimpff S., Satterlee W., Young V. et al. Empiric therapy with carbenicillin and gentamycin for febrile patients with cancer and granulocytopenia. N. Engl. J. Med. 28:1971;1061-1066.
7. Freidfeld A.G., Walsh T., Marshall D. et al. Monotherapy for fever and neutropenia in cancer patients. A randomized comparison of ceftazidime versus imipenem. Clin. Oncol. 13:1995;165-176.
8. Hauer C., Urban C., Slavc I. et al. Imipenem-cilastatin monotherapy in juvenile cancer patients with neutropenia. Pediatr. Hematol. Oncol. 7:1990;229-241.
9. Huijgens P.C., Ossenkoppele G.J. et al. Imipenem-cilastatin for empirical therapy in neutropenic patients with fever: An open study in patients with hematologic malignancies. Eur. J. Hematol. 46:1991;42-46.
10. Liang R., Yung R., Chiu E. et al. Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients. Antimicrob. Agents Chemother. 27:1990;745-748.
11. Pizzo P.A., Hathorn J.W., Hiemenz J. et al. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N. Engl. J. Med. 315:1986;552-558.
12. Rolson K., Berkey P., Bodey G. et al. A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients. Arch. Intern. Med. 152:1992;283-291.
13. Sanders J., Powe N., Moore R. Ceftazidime monotherapy for empiric treatment of febrile neutropenic patients: A meta-analysis. J. Infect. Dis. 164:1992;907-916.
14. Wade J., Standiford H., Drusano G. et al. Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer. Am. J. Med. Suppl. 5A:1985;62-72.
15. Fink M.P., Snydman D.R., Niederman M.S. et al. Treatment of severe pneumonia in hospitalized patients: Results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. Antimicrob. Agents Chemother. 38:1994;547-557.
16. Chan C.C., Oppenheim B.A., Anderson H., Swindell R., Scarffe J.H. Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients. Antimicrob. Agents Chemother. 33:1989;87-91.
17. Kelsey S.M., Collins P.W., Delord C., Weinhard B., Newland P. A randomized study of teicoplanin plus ciprofloxacin versus gentamycin plus piperacillin for the empirical treatment of fever in neutropenic patients. Br. J. Hematol. 76:1990;10-13.
18. Malik I, Kahn WA, Karim M, et al. Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: Results of a prospective randomized trial, Am J Med 1995;98:224-231.
19. Malik I., Kahn W., Aziz A., Karim M. Self-administered antibiotic therapy for chemotherapy-induced low-risk febrile neutropenia in patients with non-hematologic neoplasms. Clin. Infect. Dis. 19:1994;522-527.
20. EORTC International Antimicrobial Therapy Cooperative Group. Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram negative bacteremia in cancer patients with granulocytopenia, N Engl J Med 1989;317:1597-1698.